Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention

David D McManus1, Amir Y Shaikh, Fnu Abhishek

  • 1Departments of Medicine and Quantitative Health Sciences, University of Massachusetts Medical Center, Worcester, MA 01655, USA. mcmanusd@ummhc.org

Insights

Heart failure (HF) and atrial fibrillation (AF) share common origins due to cardiovascular risk factors. These factors drive cardiac remodeling, linking HF and AF as part of a disease continuum, highlighting opportunities for prevention.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Pathophysiology

Background:

  • Heart failure (HF) and atrial fibrillation (AF) are prevalent cardiovascular diseases with increasing global incidence.
  • Both conditions affect the atria and ventricles, often co-existing in patients.
  • Aging populations contribute to the rising prevalence of HF and AF worldwide.

Purpose of the Study:

  • To explore the mechanistic parallels between HF and AF.
  • To emphasize the role of common cardiovascular risk factors in the development of both conditions.
  • To promote strategies for the prevention of AF by understanding its links to HF.

Main Methods:

  • Review of existing literature on the pathophysiology of HF and AF.
  • Analysis of biologic pathways involved in cardiac remodeling.
  • Examination of the relationship between systemic cardiovascular risk factors and cardiac abnormalities.

Main Results:

  • HF and AF may stem from shared cardiovascular risk factors leading to atrial and ventricular remodeling.
  • Biologic pathways including neurohormonal signaling, inflammation, cell death, and fibrosis are implicated.
  • Cardiac structural and electrophysiologic remodeling contribute to rhythm disturbances like AF.

Conclusions:

  • AF and HF are not distinct diseases but represent points along a disease continuum.
  • Understanding the shared mechanisms driven by risk factors is crucial for prevention.
  • Targeting cardiovascular risk factors can potentially prevent both HF and AF.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...